Study Shows Detection of Hydrocodone and Morphine as Metabolites of Codeine
Millennium Health announced the publication of a new study that identifies hydrocodone and morphine as metabolites in oral fluid using Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS) in patients prescribed codeine. The study was published in the February 2017 issue of Therapeutic Drug Monitoring.
“Understanding that hydrocodone and morphine may be found as metabolites for patients prescribed codeine helps improve interpretation of oral fluid testing used to monitor patients prescribed opioids,” said Maria Guevara, Pharm.D., director of clinical affairs, education and training, Millennium Health. “In a clinical context, it could mean that a clinician does not falsely accuse a patient of having taken a concomitant medication.”
In the study, oral fluid samples were collected and submitted to Millennium for routine drug testing using LC-MS/MS. Consistent with previously published literature, codeine was the primary analyte detected in oral fluid after the use of codeine. In codeine-positive samples, hydrocodone, morphine, and norhydrocodone were detected. In contrast to urine, where hydrocodone is typically detected as a minor metabolite of codeine, hydrocodone was the most commonly detected metabolite in oral fluid samples testing positive for codeine with reported prescriptions for codeine.
The results of the study suggest that care should be taken when interpreting hydrocodone positives in oral fluid test results, and that the use of codeine should be considered as one possible explanation for hydrocodone and morphine positives.
West, R. E., Guevara, M. G., Mikel, C., & Gamez, R. (2017). Detection of Hydrocodone and morphine as metabolites in oral fluid by LC-MS/MS in patients prescribed Codeine. Therapeutic Drug Monitoring, 39(1), 88–90. doi:10.1097/ftd.0000000000000365
This article has been republished from materials provided by Millennium Health. Note: material may have been edited for length and content. For further information, please contact the cited source.
Researchers Uncover Muscle Growth Inhibitor Activation Mechanism Aiding ALS Treatment EffortsNews
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for limiting muscle, is activated.READ MORE
New Research Could Significantly Accelerate Drug DiscoveryNews
Scientists have developed a suite of computer programs that cull through data on structure and genomic sequencing to identify the features that distinguish one enzyme from similar enzymes. This research has the potential to significantly accelerate drug discovery, allowing scientists to develop more effective drugs, more quickly.READ MORE
New Partnership to Provide Bioanalytical and DMPK ServicesNews
Concept Life Sciences, the integrated drug discovery, development and analytical services company, and Alderley Analytical, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.